Czeremszyńska Beata, Drozda Stanisław, Górzyński Michał, Kępka Lucyna
Independent Public Health Care Facility of the Ministry of the Interior and Warmian & Masurian Oncology Center, Radiotherapy Department, Olsztyn, Poland.
Military Institute of Medicine, Warsaw, Poland.
Rep Pract Oncol Radiother. 2017 Sep-Oct;22(5):341-348. doi: 10.1016/j.rpor.2017.05.002. Epub 2017 Jun 30.
To assess prospectively which patients with left breast cancer have the dosimetric benefit from the use of deep-inspiration breath-hold radiotherapy (DIBH-RT).
Improvement in selection of patients for DIBH-RT would spare time of radiotherapy staff by removing the need for preparation of two comparative treatment plans.
Thirty-one patients qualified for whole left breast irradiation underwent breath-hold training and their free-breathing (FB) and DIBH planning-CT were included in the analysis of dosimetric outcome. Mean heart dose (MHD), heart V20 Gy (V20Heart), maximum dose to LAD (LADmax), V20 for left lung (V20L.lung) were recorded from FB and DIBH plans and the differences (Δ) of these values were calculated. If relative improvement of at least 20% for any evaluated dosimetric parameter was found for the DIBH-RT, this plan was selected for treatment. Correlations of Δ of dosimetric parameters with patient-related parameters (BMI, age, PTV, cardiac contact distance [CCD], lung volume at FB) were sought.
In 30 of 31 patients, a predefined reduction in evaluated parameters was achieved. CCD, BMI correlated positively with ΔMHD, ΔV20Heart, ΔLADmax; PTV with ΔMHD and ΔV20Heart ( < 0.05; AUC > 0.6); Lung volume correlated negatively with ΔLADmax, ΔMHD and ΔV20Heart. No specific thresholds for the lack of predefined improvement of any dosimetric parameters was identified in ROC analysis. 19/30 (63%) patients with dosimetric benefit completed their RT with DIBH.
Despite a strong correlation between patient-related and dosimetric parameters, we cannot use the anatomical characteristics' thresholds to select patients for whom DIBH-RT will not be considered.
前瞻性评估哪些左乳腺癌患者能从深吸气屏气放疗(DIBH-RT)中获得剂量学益处。
改进DIBH-RT患者的选择,可避免放疗工作人员准备两个对比治疗计划的时间。
31例符合左侧全乳照射条件的患者接受屏气训练,其自由呼吸(FB)和DIBH计划CT纳入剂量学结果分析。记录FB和DIBH计划中的平均心脏剂量(MHD)、心脏V20 Gy(V20Heart)、左前降支最大剂量(LADmax)、左肺V20(V20L.lung),并计算这些值的差异(Δ)。如果发现DIBH-RT的任何评估剂量学参数相对改善至少20%,则选择该计划进行治疗。寻找剂量学参数的Δ与患者相关参数(BMI、年龄、靶体积(PTV)、心脏接触距离[CCD]、FB时的肺体积)之间的相关性。
31例患者中有30例实现了评估参数的预定义降低。CCD、BMI与ΔMHD、ΔV20Heart、ΔLADmax呈正相关;PTV与ΔMHD和ΔV20Heart相关(P<0.05;AUC>0.6);肺体积与ΔLADmax、ΔMHD和ΔV20Heart呈负相关。ROC分析未发现任何剂量学参数缺乏预定义改善的特定阈值。19/30(63%)有剂量学益处的患者通过DIBH完成了放疗。
尽管患者相关参数与剂量学参数之间有很强的相关性,但我们不能使用解剖特征阈值来选择不考虑DIBH-RT的患者。